Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/6/2025

Acute Tonsillitis Treatment Guidelines

Introduction to Treatment

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends ceftriaxone 1-2 g/day for moderate respiratory infections 1
  • Acute bacterial tonsillitis (presumed Group A Streptococcus) is effectively treated with oral antibiotics in immunocompetent patients 2

Antibiotic Selection

  • Ceftriaxone 1-2 grams IV daily provides appropriate coverage for respiratory tract infections including pharyngitis 1
  • Cefazolin is a first-generation cephalosporin designed primarily for skin/soft tissue infections and surgical prophylaxis, not respiratory tract infections 4

Treatment Approach

  • Oral amoxicillin or penicillin V remains the first-choice antibiotic for acute bacterial tonsillitis 2
  • IV antibiotics are reserved for patients who cannot tolerate oral medications, have severe systemic toxicity, or have failed oral therapy 1

Transition and Duration

  • If IV ceftriaxone is initiated, transition to oral antibiotics after 48-72 hours once clinical improvement is documented 1
  • Total treatment duration should be 5-10 days depending on clinical response 1

Critical Considerations

  • Do not use IV antibiotics for routine uncomplicated tonsillitis—this promotes antibiotic resistance and unnecessary healthcare costs 2
  • Do not use cefazolin for respiratory tract infections—it lacks appropriate spectrum and tissue penetration 4

REFERENCES

1

Ceftriaxone Treatment Guidelines for Respiratory Infections [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Cephalosporin Regimens for Adult Acute Otitis Media [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025